Back
Apellis Pharmaceuticals Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
16
APLS
Apellis Pharmaceuticals
Last Price:
$17.46
Seasonality Move:
-4.83%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.51 | Sell |
| 20-day SMA: | 18.1 | Sell |
| 50-day SMA: | 20.88 | Sell |
| 200-day SMA: | 29.17 | Sell |
| 8-day EMA: | 17.41 | Sell |
| 20-day EMA: | 18.32 | Sell |
| 50-day EMA: | 20.74 | Sell |
| 200-day EMA: | 29.34 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 30.44 | Sell |
| Chaikin Money Flow: | -461015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.23 - 19.31) | Sell |
| Bollinger Bands (100): | (20.05 - 30.73) | Sell |
Apellis Pharmaceuticals Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 16.36 while APLS 8-day simple moving average is 17.51, which is a Sell signal.
-
The stock price of APLS is 16.36 while Apellis Pharmaceuticals 20-day SMA is 18.10, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 20.88 while APLS share price is 16.36, making it a Sell technically.
-
APLS stock price is 16.36 and Apellis Pharmaceuticals 200-day simple moving average is 29.17, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
16
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $16.36. The Score for APLS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.1B
Price in USD:
16.36
Share Volume:
2.5M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
43.99
52-Week Low:
16.10
Sell
16
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 16.36 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 16.36 while APLS 8-day exponential moving average is 17.41, which is a Sell signal.
-
The stock price of APLS is 16.36 while Apellis Pharmaceuticals 20-day EMA is 18.32, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 20.74 while APLS share price is 16.36, making it a Sell technically.
-
APLS stock price is 16.36 and Apellis Pharmaceuticals 200-day simple moving average is 29.34, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -1.04, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 30.44, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.23 - 19.31), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (20.05 - 30.73), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.